Nikkiso Co., Ltd. Announces Consolidated Financial Results for the Six Months Ended June 30, 2019; Provides Consolidated Financial Guidance for the Year Ending December 31 2019
August 08, 2019
Share
Nikkiso Co., Ltd. announced consolidated financial results for the six months ended June 30, 2019. For the period, the company reported revenue of JPY 78,956 million against JPY 75,578 million for the same period a year ago. Operating profit was JPY 3,558 million against JPY 3,168 million for the same period a year ago. Profit for the year was JPY 2,003 million against JPY 2,104 million for the same period a year ago. Basic earnings per share were JPY 26.76 per share against JPY 28.57 per share for the same period a year ago. Diluted earnings per share were JPY 26.72 per share against JPY 25.18 per share for the same period a year ago.
For the year ending December 31 2019, the company expects revenue to be JPY 170,000 million. Operating income is expected to be JPY 12,000 million. Profit for the year attributable to owners of the company is expected to be JPY 8,200 million. Basic earnings per share is expected to be JPY 115.19 per share.
NIKKISO CO.,LTD. is a Japan-based company principally engaged in the manufacture and sale of industrial pumps, precision equipment and blood related products, among others. The Company operates in two business segments. Industrial Business segment conducts industrial business including the manufacture, sale and maintenance of industrial special pumps, as well as liquefied gas & industrial gas related equipment and devices. The Segment is also involved in precision equipment business, aerospace business and deep ultraviolet light emitting diode (LED) business. Medical Business segmentâs products are dialysis-related products including hemodialysis and peritoneal dialysis, such as artificial dialysis machines, dialyzers, blood circuits, and powder-type dialysis agents. The Segment also manufactures, sells and maintains products and medicines related to CRRT (acute blood purification therapy), artificial pancreas devices that manage blood glucose, and energy devices for microwave surgery.
Nikkiso Co., Ltd. Announces Consolidated Financial Results for the Six Months Ended June 30, 2019; Provides Consolidated Financial Guidance for the Year Ending December 31 2019